How long before semaglutide kicks in — and what the trial evidence actually shows

What the STEP 1 data tells us about early versus later response

The STEP 1 trial enrolled 1,961 adults with obesity and tracked them across 68 weeks. The headline finding (roughly 15% average weight loss at the 2.4 mg maintenance dose) tells you where the destination is, but not the journey. Looking at the trial's week-by-week data, weight loss followed a clear pattern: modest in the first month, more noticeable from around week eight onward, and continuing to accumulate well beyond the point at which many people expect to plateau.

The reason early weeks feel slow is structural. The dose starts at 0.25 mg weekly, a level chosen almost entirely for tolerability rather than effect. At that concentration, GLP-1 receptor activity is present but limited. As the dose steps up (roughly every four weeks) the appetite-suppressing signal strengthens. Most people notice a genuine shift in hunger somewhere between weeks four and eight, though for some it arrives earlier and for others it takes a little longer to become unmistakable.

A useful reference from the NHS medicines page for semaglutide: it takes time for the medicine to reach its therapeutic effect, and the dose-escalation schedule is there to protect you from unnecessary side effects in the process. That context matters when the first fortnight feels underwhelming.

The appetite change usually comes before the scales move

A question our prescribers hear most weeks: "I've had two injections and I haven't lost anything (is it working?" Almost always, the honest answer is yes, probably) just not yet visibly. The sequence tends to run: appetite softness first, then smaller portion sizes, then the energy deficit that produces measurable weight change. The scales are the last thing to move, not the first signal that semaglutide is active.

This matters because people who judge the medicine purely by early weigh-ins sometimes conclude it isn't working and request a dose increase before the current dose has had time to settle. The escalation schedule is clinically deliberate, rushing it typically increases gastrointestinal side effects without meaningfully accelerating results. Nausea, for instance, is most common after a dose step and usually settles within one to two weeks as the body adjusts.

If you're trying to understand whether your own response is typical, the guide to how long Wegovy takes to work covers the practical week-by-week picture in more depth, including what to expect at each dose stage.

By how much does weight loss differ between maintenance doses, and when?

Reaching the 2.4 mg maintenance dose takes a minimum of around 16 to 20 weeks under the standard titration schedule. If you want a closer look at how long till semaglutide kicks in across those escalation steps, that context reshapes the timeline question considerably, because the dose-escalation phase itself accounts for a significant portion of the wait.

Once at maintenance, the trial data shows weight loss continuing for many months. The STEP 1 curve had not fully flattened at week 68. In practice, the most substantial monthly losses tend to occur between roughly weeks 12 and 36, with a slower rate of change after that, though weight is still being lost, not regained, in most participants who stay on treatment.

The newer 7.2 mg maintenance dose, approved by the MHRA in January 2026 and available as a dedicated single-dose pen from April 2026, recorded around 20.7% average weight loss over 72 weeks in its trial population, a result that narrows the gap with tirzepatide. If you're weighing up options, the Wegovy overview explains both formulations and what the licensing differences mean in practice. Cost context, including how the private market has moved since Eli Lilly's 2025 list-price changes, is covered on the Wegovy price comparison page.

What affects your personal timeline

Trial averages are population figures. Your actual timeline depends on several things the average cannot capture. Starting BMI plays a role, people with a higher starting weight often see larger absolute losses earlier, even if the percentage takes longer to accumulate. Dietary changes run alongside the medicine, not instead of it: protein adequacy, hydration and not significantly under-eating all influence how well the body responds. Activity level, sleep quality and whether other medicines interact with semaglutide's absorption are also relevant factors. Our detailed breakdown of how long for semaglutide to kick in explains how these individual variables can shift your personal timeline earlier or later than the trial average, and our separate guide covers how long before Wegovy kicks in when you're specifically using the branded pen.

Semaglutide is not licensed for use during pregnancy, breastfeeding, or when trying to conceive, and it is not approved for under-18s. Certain conditions (including a history of pancreatitis) require careful prescriber assessment. The MHRA updated its safety guidance for GLP-1 medicines in January 2026 to highlight acute pancreatitis as an infrequent but serious risk; anyone on semaglutide experiencing severe stomach pain that reaches the back should seek medical attention promptly and can report suspected side effects via the MHRA Yellow Card scheme.

If you'd like to explore whether semaglutide is the right option for your situation, our clinical team reviews every consultation personally. You can read more about how nume works or take a look at the full range of weight-loss treatment options before deciding. When you're ready, check your eligibility with a free consultation, a GPhC-registered prescriber, not software, reads your answers the same day.